Search research articles
Contact Us
Filters
Showing results (31-40 of 114) with videos related to
Page
of 12
Sort By:
Leukemia Research
|
October 24, 2019
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation
Ryotaro Nakamura, Ketevan Gendzekhadze, Joycelynne Palmer, et al.
Frontiers in Oncology
|
December 19, 2022
Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy
Colton Ladbury, Claire Hao, Dongyun Yang, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 16, 2024
Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia
Dat Ngo, Jose Tinajero, Jianying Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study
Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
British Journal of Haematology
|
June 10, 2025
The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B-cell precursor acute lymphoblastic leukaemia in measurable residual disease-negative remission
Jose Tinajero, Dat Ngo, Maria Motta, et al.
Transplantation and Cellular Therapy
|
September 27, 2022
Risk of Subsequent Malignant Neoplasms Following Hematopoietic Stem Cell Transplantation with Total Body Irradiation or Total Marrow Irradiation: Insights from Early Follow-Up
Colton Ladbury, Saro Armenian, Alysia Bosworth, et al.
Haematologica
|
October 15, 2020
Exosomes-driven lipolysis and bone marrow niche remodeling supports leukemia expansion
Bijender Kumar, Marvin Orellana, Jamison Brooks, et al.
Leukemia & Lymphoma
|
January 2, 2024
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib
Dat Ngo, Jose Tinajero, Shanpeng Li, et al.
American Journal of Clinical Oncology
|
March 14, 2024
Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Multiple Myeloma
Colton Ladbury, James Sanchez, Arnab Chowdhury, et al.
Blood Reviews
|
March 25, 2020
Targeting MCL-1 in hematologic malignancies: Rationale and progress
Andrew H Wei, Andrew W Roberts, Andrew Spencer, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 114) with videos related to
Sort By:
Page
of 12
Leukemia Research
|
October 24, 2019
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation
Ryotaro Nakamura, Ketevan Gendzekhadze, Joycelynne Palmer, et al.
Frontiers in Oncology
|
December 19, 2022
Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy
Colton Ladbury, Claire Hao, Dongyun Yang, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 16, 2024
Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia
Dat Ngo, Jose Tinajero, Jianying Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study
Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
British Journal of Haematology
|
June 10, 2025
The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B-cell precursor acute lymphoblastic leukaemia in measurable residual disease-negative remission
Jose Tinajero, Dat Ngo, Maria Motta, et al.
Transplantation and Cellular Therapy
|
September 27, 2022
Risk of Subsequent Malignant Neoplasms Following Hematopoietic Stem Cell Transplantation with Total Body Irradiation or Total Marrow Irradiation: Insights from Early Follow-Up
Colton Ladbury, Saro Armenian, Alysia Bosworth, et al.
Haematologica
|
October 15, 2020
Exosomes-driven lipolysis and bone marrow niche remodeling supports leukemia expansion
Bijender Kumar, Marvin Orellana, Jamison Brooks, et al.
Leukemia & Lymphoma
|
January 2, 2024
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib
Dat Ngo, Jose Tinajero, Shanpeng Li, et al.
American Journal of Clinical Oncology
|
March 14, 2024
Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Multiple Myeloma
Colton Ladbury, James Sanchez, Arnab Chowdhury, et al.
Blood Reviews
|
March 25, 2020
Targeting MCL-1 in hematologic malignancies: Rationale and progress
Andrew H Wei, Andrew W Roberts, Andrew Spencer, et al.
Page
of 12